Bristol-Myers CEO Caforio announces retirement
PRINCETON, N.J. — Bristol-Myers Squibb CEO Giovanni Caforio is set to retire, with chief commercialization officer Christopher Boerner taking over the position on November 1. Caforio, who has been at the helm since 2015, will continue in his role as executive chairman. Under his leadership, the company cemented its status as a leading cancer treatment
